1. Presence of Multi-Morbidities and Colorectal Cancer Screening Utilization among Breast Cancer Survivors
   Meng-Han Tsai et al, 2023, Cancers CrossRef
2. A pharmacovigilance study of etoposide in the FDA adverse event reporting system (FAERS) database, what does the real world say?
   Zhiwei Cui et al, 2023, Front. Pharmacol. CrossRef
3. Clinicopathological features, prognostic factor analysis, and survival nomogram of patients with double primary cancers involving lung cancer
   Yuxuan Hao et al, 2024, Cancer Medicine CrossRef